HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Daschle’s Exit Cedes Control Of Health Care Reform To Baucus, Waxman

This article was originally published in The Tan Sheet

Executive Summary

The Obama administration's formula for making comprehensive health care reform work in 2009 was straightforward: have an experienced team in place in all of the relevant health and budget areas immediately; prepare a manageable piece of legislation for early in the first year; and rely on the political clout of the perfect political general to keep Congress focused and in line

You may also be interested in...



Plan For Spending Comparative Effectiveness Money Due July 30

Questions swirling around the $1.1 billion in comparative effectiveness research funding should be answered by July 30, the due date for a report to Congress with details of how the money provided in the economic stimulus package for the research will be spent

HHS Staff Appointments Bring Ties To HELP Committee, Sen. Baucus

Top staff members recently added at the Department of Health and Human Services bring ties to key health policy figures or Senate committees

Daschle Withdrawal Shuffles Lead Roles On Health Care Reform Stage

Tom Daschle's withdrawal as Health and Human Services secretary nominee could improve the chances for comprehensive health care reform in the near term, Sen. Bob Bennett, R-Utah, suggests

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS135959

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel